ArticleBlood advances2022

The dosing of ibrutinib and related Bruton's tyrosine kinase inhibitors: eliminating the use of brute force.

Mark J Ratain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.